Pediatrix Medical Group, Inc. Revenue 2016–2025
Pediatrix Medical Group, Inc. annual/quarterly revenue history and growth rate from 2016 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Pediatrix Medical Group, Inc. revenue for the quarter ending March 31, 2026 was 476.2 M, a 3.89% increase year-over-year.
- Pediatrix Medical Group, Inc. revenue for the twelve months ending March 31, 2026 was 1.9 B, a 5.99% decrease year-over-year.
- Pediatrix Medical Group, Inc. annual revenue for 2025 was 1.9 B, a 4.92% decrease from 2024.
- Pediatrix Medical Group, Inc. annual revenue for 2024 was 2.0 B, a 0.92% increase from 2023.
- Pediatrix Medical Group, Inc. annual revenue for 2023 was 2.0 B, a 1.15% increase from 2022.
- Pediatrix Medical Group, Inc. annual revenue for 2022 was 2.0 B.
Pediatrix Medical Group, Inc. (MD) — Frequently Asked Questions
Pediatrix Medical Group, Inc. (MD) is a publicly traded US company. It has a market capitalization of $2.05B. In fiscal 2025 it reported revenue of $1.91B and net income of $165M. Explore MD's stock price, financial statements, earnings history, margins and key ratios below.
What is Pediatrix Medical Group, Inc.'s market cap?
Pediatrix Medical Group, Inc. (MD) has a market capitalization of $2.05B.
What is the MD stock price?
MD trades at $24.10 (+2.29% on the day).
How much revenue does Pediatrix Medical Group, Inc. make?
Pediatrix Medical Group, Inc. reported revenue of $1.91B in fiscal 2025.
Is MD profitable?
In fiscal 2025, Pediatrix Medical Group, Inc. reported net income of $165M.
What is MD's P/E ratio?
Based on diluted EPS, MD has a price-to-earnings (P/E) ratio of about 12.4.